La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 14 April 2026)
| Date | 14 April 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Application Rop 223 |
| Case number(s) | UPC_CoA_48/2026 |
| Registry reference | UPC-COA-0000048/2026 |
| Parties | La Siddhi Consultancy Limited. v. Athena Pharmaceutiques SAS, Substipharm |
Official decision (PDF) · UPC registry entry
Case timeline
- 1 June 2026 : La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) UPC_CoA_48/2026
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 14 April 2026 (UPC_CoA_48/2026), the Court of Appeal rejects La Siddhi Consultancy’s application for suspensive effect against the Milan Central Division’s order of 13 March 2026, which required it to provide EUR 75,000 security for costs in its revocation action on EP 3 592 333 against Athena Pharmaceutiques and Substipharm. The order confirms that suspensive effect remains exceptional and that SME status does not dispense with concrete proof of inability to pay.
Question
Should an appeal against an order for security for costs, brought with leave under Rule 220.2, be given suspensive effect?
Decision
The application is admissible, since Art. 74 UPCA allows suspensive effect for Rule 220.2 orders and prevails over the Rules (paragraphs 8 and 9). It is unfounded: suspensive effect requires exceptional circumstances, such as an appeal that would otherwise be devoid of purpose, a manifestly wrong decision or a serious breach of procedural rights (paragraphs 10 to 13). The applicant shows neither a manifest error nor a breach of the right to be heard, the correctness of the reasoning being a matter for the appeal (paragraph 15), nor inability to pay, SME status alone being insufficient (paragraphs 16 and 17). The appeal keeps its purpose, as a deposit can be refunded or a guarantee released, and Art. 47 of the Charter is not infringed (paragraph 18). No costs order is made (paragraph 19).
Key points for practice
- Because security for costs is reversible, enforcing it does not deprive the appeal of its purpose and does not, as a rule, justify suspensive effect.
- Inability to provide the security must be shown by concrete financial evidence.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 69(4) and 74(1)
- Rules of Procedure
- Rules 1.1, 158, 220.2 and 223
- Case law cited
- ICPillar v ARM, Court of Appeal, 19 June 2024, Sun Patent Trust v Vivo, Court of Appeal, 25 August 2025, Ocado v Autostore, Court of Appeal, 6 November 2023, Progress Maschinen v AWM, Court of Appeal, 2 May 2024, Meril v Edwards, Court of Appeal, 18 January 2024, Windhager v Bellissa, Court of Appeal, 2 December 2025, Alpina v Cup&Cino, Court of Appeal, 24 March 2026, Belkin v Philips, Court of Appeal, 29 October 2024, Chint v Jingao, Court of Appeal, 20 May 2025, Guardant Health v Sophia Genetics, Court of Appeal, 18 February 2026
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantLa Siddhi Consultancy Limited4 decisions in the corpusFollow this party
- defendantAthena Pharmaceutiques SAS4 decisions in the corpusFollow this party
- defendantSubstipharm4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 14 April 2026 La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 14 April 2026) Application Rop 223 · UPC_CoA_48/2026
- 1 June 2026 La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) Appeal RoP220.2 · UPC_CoA_48/2026
L’appel est rejeté : la garantie de 75 000 euros est maintenue, la qualité de PME ne dispensant pas à elle seule de fournir une garantie pour les frais.
What the record states
- Nature of the act
- Application Rop 223
- Outcome (Dhenne Avocats summary)
- La cour d'appel rejette la demande d'effet suspensif visant l'ordonnance imposant une garantie de 75 000 EUR, faute d'erreur manifeste, d'atteinte aux droits procéduraux ou de preuve de l'incapacité de payer.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 3 592 333mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) cited in this record
- ALPINA Coffee Systems v CUP&CINO Kaffeesystem-Vertrieb (CoA, 24 March 2026) cited in this record
- La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 13 March 2026) cited in this record
- Guardant Health v Sophia Genetics (CoA, 18 February 2026) cited in this record
- Windhager Handelsgesellschaft v bellissa HAAS (CoA, 2 December 2025) cited in this record
- Sun Patent Trust v Vivo Mobile Communication (CoA, 25 August 2025) cited in this record
- Koninklijke Philips v Belkin (CoA, 29 October 2024) cited in this record
- ICPillar v ARM (CoA, 19 June 2024) cited in this record
- Meril Life Sciences v Edwards Lifesciences (CoA, 18 January 2024) cited in this record
- Siemens Healthineers v Hologic (CoA, 15 July 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 592 333 | Mentioned in the analysis (role not qualified) Also mentioned in 3 other decision(s): La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) · La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 19 May 2026) · La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 13 March 2026) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.